Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Regulus Therapeutics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 63 | 2 | 70 | +9 |
| Shares | 61.3M | 4.37M | 56.7M | −229.6K (−0.4%) |
| Value | $109.5M | $7.80M | $89.1M | −$12.6M (−12.4%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Regulus Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,081,038 | $6.41M | 0.00% |
| Point72 Asset Management, L.P. | 893,762 | $1.40M | 0.00% |
| TD Asset Management Inc | 302,000 | $486.2K | 0.00% |
| Manufacturers Life Insurance Company, The | 129,700 | $203.6K | 0.00% |
| American Century Companies Inc | 38,681 | $60.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 35,154 | $55.2K | 0.00% |
| AQR Capital Management LLC | 30,209 | $47.4K | 0.00% |
| Jane Street Group, LLC | 29,580 | $46.4K | 0.00% |
| SG Americas Securities, LLC | 20,800 | $33.0K | 0.00% |
| HSBC Holdings PLC | 19,224 | $29.7K | 0.00% |
| Creative Planning | 16,466 | $25.9K | 0.00% |
| ProShare Advisors LLC | 11,932 | $18.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,914 | $10.9K | 0.00% |
| CWM, LLC | 386 | $1.00K | 0.00% |
| Continuum Advisory, LLC | 300 | $450 | 0.00% |
| Sterling Capital Management LLC | 166 | $261 | 0.00% |
| Citadel Advisors LLC | 32 | $50 | 0.00% |
Sold out (8)
Institutions that held Regulus Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| ExodusPoint Capital Management, LP | 329,639 | $588.0K |
| Hudson Bay Capital Management LP | 249,940 | $446.1K |
| Alpine Global Management, LLC | 59,004 | $105.3K |
| Two Sigma Securities, LLC | 38,451 | $68.6K |
| MetLife Investment Management | 16,779 | $30.0K |
| Prelude Capital Management, LLC | 14,100 | $25.2K |
| Simplex Trading, LLC | 3,622 | $6.00K |
| Parallel Advisors, LLC | 10 | $18 |
Not filed for Q3 2024 yet (2)
Institutions that held Regulus Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,968,857 | $7.08M |
| CVI Holdings, LLC | 401,012 | $715.8K |